|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 09, 2012 ) New York, NY -- This week's 'Weekly Stock Watch' from VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, keys in on some company's whose shares experienced an increase in trading volume last week and may be looking to make price gains during the coming week.
It is also time to start paying attention to earnings report, which could play a key role in setting the pace for trading patterns that may dominate the summer months.
For full report and list of this week's hot stocks to watch, visit: http://vfcsstockhouse.com/blog/article/-weekly-stock-watch-week-of-july-9-jpm-aa-goog-ssh-mnkd-mric-sppi-jazz-pbth-teva-mrk-lptn-pfe-gnbt-ctso-tlle-fb-yhoo-imsc
The news flow eased somewhat from Europe last week, forcing investors to key mainly on indications pertaining solely to the state of the US economy and its respective recovery. Jobs and unemployment numbers disappointed on that front, however, and Friday's 100-plus point drop on the DOW could be an indicator that investors also expect lackluster numbers to start pouring in from the new earnings season. Those same investors may also be taking a 'wait and see' approach regarding additional economic indicators, which should be forthcoming on Wednesday when the Fed releases its minutes.
While the week ended on a down note, the dramatic volatile shifts of previous weeks failed to materialize this time. It's possible, if last week's action is a judge, that a little bit more stability will be upon us during the summer months. There's likely to be some shift in action though, as the media outlets and politicians trump any and all economic data to feed their respective agendas regarding the upcoming presidential campaign, which is likely to start getting pretty heated real soon.
Sunshine Heart (SSH): With a close like last Friday's, Sunshine Heart will be a hot stock to watch this week. On volume of nearly forty times the daily average, both Thursday and Friday of last week, shares of SSH soared over sixty percent higher, while reaching even higher during intra-day trading.
As outlined last Tuesday, Sunshine Heart could start attracting its fair share of new investor interest as its potential breakthrough medical device designed to treat the unmet medical need of Class III and ambulatory Class IV heart failure makes significant progress towards market.
The C-Pulse Heart Assist System is implanted in a patients heart, although outside of the blood stream, and has proven to not only halt the progression of heart failure while improving a patient's performance and quality-of-life, but possibly even reversing the effects, as well.
Mannkind Corp (MNKD): Just weeks after making a push for the two dollar mark, Mannkind is now pushing three. Another two percent jump on Friday helped MNKD shares close the week at $2.75, a full buck above its closing price of a month ago, and some recent hype surrounding insider buys once again has investors interested in this stock.
MRI Interventions (MRIC): MRI Interventions is another company whose shares have been on fire lately. Having well more than tripled in price within weeks, MRIC touched the five dollar mark last week before retreating on Friday to close the day at $3.40. Volume was up big during the run - and still looked to be growing - as investors continued to jump on board of the company's growing success story.
Spectrum Pharmaceuticals (SPPI): Shares of Spectrum Pharmaceuticals continue to fly higher, setting new 52-week highs last week amid robust short interest that has had this stock on the radar as a 'mother of all short squeezes' play for weeks.
Prolor Biotech (PBTH): Prolor Biotech remained trading above the five dollar mark for the duration of the week last week, bar a Monday dip to below that mark, and the latest lull in news flow and relative drop in volume may provide those investors looking towards the development of hGH-CTP the opportunity to slowly accumulate.
Lpath, Inc. (LPTN): Lpath is another stock that may be gearing up for a move back to the dollar mark, as they were cruising along earlier this year at prices over the dollar mark - supported by volume fluid enough to sustain those levels - until two proof-of-concept trials for iSONEP, PEDigree for the treatment of retinal pigment epithelium detachment ("RPE detachment" or "PED") and NEXUS, targeting Wet AMD, were halted earlier this year due to FDA compliance issues with Lpath's finish/fill contractor.
Teletouch Communications (TLLE): Still a potential growth story based on a few recently realized developments, Teletouch Communications continues to trade under the radar while solidifying its redirected business plan that heavily emphasizes distribution and hardware sales, mainly through the company's primary subsidiary.
Contact VFC's Stock House: vfc@vfcsstockhouse.com
Originally published at: http://vfcsstockhouse.com
Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse
'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213
About VFCsStockHouse.com:
VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks, biopharma stocks, growth stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.
For full disclaimer visit: http://vfcsstockhouse.com
VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
